Eric Lefebvre - Jan 25, 2023 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Chief Medical Officer
Signature: /s/ Mike Ouimette, attorney-in-fact
Stock symbol: PLRX
Transactions as of: Jan 25, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/27/2023, 06:15 PM
Previous filing: Jan 25, 2023
Next filing: Mar 31, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PLRX	Common Stock	Award	$0	+57K	+74.1%	$0.00	134K	Jan 25, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (right to buy)	Award	$0	+80K		$0.00	80K	Jan 25, 2023	Common Stock	80K	$34.65	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These are restricted stock units that vest in three equal annual installments beginning January 16, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
F2	1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.